Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan
暂无分享,去创建一个
K. Uchimaru | Toshiki Watanabe | K. Ohno-Matsui | K. Kamoi | A. Okayama | I. Hamaguchi | A. Tojo | S. Izumo
[1] K. Ohno-Matsui,et al. Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions in vitro , 2019, Front. Microbiol..
[2] A. Thomas. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics , 2019, Current opinion in ophthalmology.
[3] S. Shimada,et al. Towards the elimination of HTLV-1 infection in Japan. , 2019, The Lancet. Infectious diseases.
[4] K. Gruber. Australia tackles HTLV-1. , 2018, The Lancet. Infectious diseases.
[5] R. Gallo,et al. Time to eradicate HTLV-1: an open letter to WHO , 2018, The Lancet.
[6] M. Mochizuki,et al. Human T Cell Leukemia Virus Type 1 and Eye Diseases. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[7] K. Miyata,et al. Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions , 2017, Medicine.
[8] M. Satake,et al. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis. , 2016, The Lancet. Infectious diseases.
[9] M. Mochizuki,et al. HTLV infection and the eye , 2012, Current opinion in ophthalmology.
[10] Koju Kamoi,et al. HTLV-1 uveitis , 2012, Front. Microbio..
[11] M. Satake,et al. Current prevalence of HTLV‐1 in Japan as determined by screening of blood donors , 2012, Journal of medical virology.
[12] Toshiki Watanabe. Current status of HTLV-1 infection , 2011, International journal of hematology.
[13] S. Kamihira,et al. Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000–2006 , 2009, International journal of hematology.
[14] K. Yamaguchi,et al. Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area , 2008, International journal of hematology.
[15] Justine R. Smith,et al. Biologic therapies for inflammatory eye disease , 2006, Clinical & experimental ophthalmology.
[16] M. Michel,et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease. , 2003, The Journal of rheumatology.
[17] N. Ohba,et al. Clinical features of HTLV-I associated uveitis. , 1993, The British journal of ophthalmology.
[18] K. Yamaguchi,et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. , 1992, The Journal of infectious diseases.
[19] K. Yamaguchi,et al. Uveitis associated with human T-cell lymphotropic virus type I. , 1992, American journal of ophthalmology.
[20] Mitsuhiro Osame,et al. HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.
[21] F. Barin,et al. ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.
[22] K. Yamaguchi,et al. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Nagata,et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[24] John D. Minna,et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.
[25] K. Yamaguchi,et al. A multicenter case-control study of HTLV-I associated uveitis. Study Group for HTLV-I Associated Ocular Diseases. , 1994, Japanese journal of ophthalmology.
[26] I. Maruyama,et al. Ocular manifestations in patients infected with human T-lymphotropic virus type I. , 1989, Japanese journal of ophthalmology.